Jointown Pharmaceutical Group Company Limited’s Net Profit Rose 1.9% in First Half of 2023

Jointown Pharmaceutical Group Company Limited (九州通医药集团股份有限公司) (600998.SH) reported a net profit of 1.4 billion yuan in the first half of 2023, up 1.9% year-on-year.

Meanwhile, the company posted 79.4 billion yuan in revenue, up 16.7% year-on-year.

At the end of the reporting period, it had 94.2 billion yuan in total assets and 65.1 billion yuan in total liabilities, with a liability-to-asset ratio of 69.1%.